RNAZ stock

Transcode Therapeutics Inc (RNAZ) financials · $5.1M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Transcode Therapeutics Inc (RNAZ) $5.1M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$28.0M-$15.7M
Net Income-$34.7M-$16.8M
EPS (Diluted)-$52.59-$47.14
Cached annual balance sheet
LineFY2025FY2024
Total Assets$162.4M$7.29M
Current Assets$22.0M$7.09M
Cash & Equivalents$17.8M$5.81M
PP&E$370.7K$51.6K
Total Liabilities$10.5M$9.31M
Current Liabilities$3.49M$2.77M
Shareholders' Equity$10.3M-$2.02M
Retained Earnings-$97.9M-$63.2M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$19.5M-$13.3M
CapEx$6.66K$21.8K
Investing Cash Flow-$4.44K-$21.8K
Financing Cash Flow$31.5M$16.4M
Net Change in Cash$12.0M$3.04M
Free Cash Flow-$19.5M-$13.4M
These statements as JSON? API free 100/day

FAQ

What is RNAZ P/E and revenue?

Transcode Therapeutics Inc (RNAZ) $5.1M cap.

What is RNAZ revenue?

RNAZ income-statement cache has no revenue figure yet.

Is RNAZ profitable?

Transcode Therapeutics Inc last cached net income is -$34.7M (FY2025).

What are RNAZ total assets?

Transcode Therapeutics Inc last cached total assets are $162.4M (FY2025).

What is RNAZ free cash flow?

Transcode Therapeutics Inc last cached free cash flow is -$19.5M (FY2025).

Not investment advice. Cached statements, not a live tape.